Oral manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome and their correlation to cluster of differentiation lymphocyte count in population of North-East India in highly active antiretroviral therapy era

被引:9
|
作者
Nayak, Sarat Kumar [1 ]
Das, Bijay Kumar [1 ]
Das, Surya Narayan [1 ]
Mohapatra, Namita [2 ]
Nayak, Suryakanti [1 ]
Bhuyan, Lipsa [3 ]
机构
[1] SCB Dent Coll & Hosp, Dept Oral Pathol & Microbiol, Cuttack 753007, Orissa, India
[2] SCB Dent Coll & Hosp, Dept Med, Cuttack, Orissa, India
[3] Kalinga Inst Dent Sci, Dept Oral & Maxillofacial Pathol, Bhubaneswar, Odisha, India
关键词
Acquired immunodeficiency syndrome; antiretroviral therapy; cluster of differentiation 4; human immunodeficiency virus;
D O I
10.4103/0976-237X.194122
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: The human immunodeficiency virus (HIV) infection which manifests as acquired immunodeficiency syndrome (AIDS) is a disease involving the defects of the T-lymphocyte arm of the immune system. Certain laboratory parameters such as the cluster of differentiation (CD4) count and clinical parameters have long been used as markers of disease progression. In industrialized countries, many studies show a highly correlation between the incidence of oral lesions and immunosuppression and hence, can be used as a marker of immunosuppression. This might not be applicable to a developing country like India. In this study, efforts have been made to supplement the present knowledge on various aspects of oral manifestations in HIV patients in the Indian subcontinent. Aims: To correlate the oral manifestations in HIV/AIDS patients to the level of circulating CD4+ T-lymphocyte count and their effect in anti-retroviral therapy (ART). Subjects and Methods: A total of 104 HIV positive patients were examined for oral lesions. The CD4 count estimated on the same day by fluorescent activated cell sort count machine was then correlated with various oral lesions. Results: Oral manifestations appeared when CD4 count decreased below 500 cells/mm(3). Moreover, oral lesions found at different stages showed very strong correlation to their respective CD4 count. Furthermore, there was considerable decline in the incidence of oral manifestations in patients undergoing highly active ART. Conclusions: Oral manifestations are highly predictive markers of severe immune deterioration and disease progression in HIV patients.
引用
收藏
页码:539 / 543
页数:5
相关论文
共 50 条
  • [31] Human Immunodeficiency Virus Infection: Does Highly Active Antiretroviral Therapy Influence Ear Nose Throat Manifestations?
    Dosemane D.
    Kumar V.
    Madi D.
    Kanthila J.
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2018, 70 (4) : 555 - 558
  • [32] Vitreoretinal manifestations of human immunodeficiency virus infection and acquired immunodeficiency syndrome in patients attending an antiretroviral therapy clinic in Nigeria: A cross sectional study
    Babalola, Yewande O.
    Oluleye, Tunji S.
    Ashaye, Adeyinka O.
    JOURNAL OF CLINICAL SCIENCES, 2022, 19 (03) : 73 - 79
  • [33] CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus load
    Miller, V
    Staszewski, S
    Sabin, C
    Carlebach, A
    Rottmann, C
    Weidmann, E
    Rabenau, H
    Hill, A
    Lepri, AC
    Phillips, AN
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02): : 530 - 533
  • [34] Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era
    Ronald A. Cohen
    Jaroslaw Harezlak
    Giovanni Schifitto
    George Hana
    Uraina Clark
    Assawin Gongvatana
    Robert Paul
    Michael Taylor
    Paul Thompson
    Jeffery Alger
    Mark Brown
    Jianhui Zhong
    Thomas Campbell
    Elyse Singer
    Eric Daar
    Deborah McMahon
    Yuen Tso
    Constantin T. Yiannoutsos
    Bradford Navia
    Journal of NeuroVirology, 2010, 16 : 25 - 32
  • [35] Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era
    Cohen, Ronald A.
    Harezlak, Jaroslaw
    Schifitto, Giovanni
    Hana, George
    Clark, Uraina
    Gongvatana, Assawin
    Paul, Robert
    Taylor, Michael
    Thompson, Paul
    Alger, Jeffery
    Brown, Mark
    Zhong, Jianhui
    Campbell, Thomas
    Singer, Elyse
    Daar, Eric
    McMahon, Deborah
    Tso, Yuen
    Yiannoutsos, Constantin T.
    Navia, Bradford
    JOURNAL OF NEUROVIROLOGY, 2010, 16 (01) : 25 - 32
  • [36] Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era
    Lee, Shinwon
    Lee, Sun Hee
    Lee, Jeong Eun
    Kang, Jin Suk
    Lee, Seung Geun
    Chung, Joo Seop
    Kwak, Ihm Soo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2017, 32 (09) : 1445 - 1450
  • [37] Human immunodeficiency virus-associated plasmablastic lymphoma: Poor prognosis in the era of highly active antiretroviral therapy
    Castillo, Jorge J.
    Furman, Michael
    Beltran, Brady E.
    Bibas, Michele
    Bower, Mark
    Chen, Weina
    Diez-Martin, Jose L.
    Liu, Jane J.
    Miranda, Roberto N.
    Montoto, Silvia
    Nanaji, Nahid M.
    Navarro, Jose-Tomas
    Seegmiller, Adam C.
    Vose, Julie M.
    CANCER, 2012, 118 (21) : 5270 - 5277
  • [38] Human papillomavirus in the era of highly active antiretroviral therapy for human immunodeficiency virus: an immune reconstitution-associated disease?
    Meys, R.
    Gotch, F. M.
    Bunker, C. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (01) : 6 - 11
  • [39] Use of complementary and alternative therapies by patients with human immunodeficiency virus disease in the era of highly active antiretroviral therapy
    Bica, I
    Tang, AM
    Skinner, S
    Spiegelman, D
    Knox, T
    Gorbach, S
    Wilson, IB
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2003, 9 (01) : 65 - 76
  • [40] Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy
    Grau, I
    Pallares, R
    Tubau, F
    Schulze, MH
    Llopis, F
    Podzamczer, D
    Liñares, J
    Gudiol, F
    ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (13) : 1533 - 1540